
AMN Stock Forecast & Price Target
AMN Analyst Ratings
Bulls say
AMN Healthcare Services Inc reported 2Q25 revenue of $658.2 million, which, despite being down 11% year-over-year, exceeded both internal estimates and consensus forecasts. The company's gross margin increased significantly to 29.8%, surpassing its guidance range, reflecting improved operational efficiency. Additionally, AMN has shown consistent performance with an average surprise in revenue and EBITDA of +3% and +12%, respectively, over the past four quarters, indicating the company's resilience in a challenging market.
Bears say
AMN Healthcare Services Inc reported a decrease in segment revenue for its nurse and allied solutions segment, down 9% year-over-year to $101.8 million, with a gross margin decline of 40 basis points from the previous quarter. Additionally, the company faced a significant 14% year-over-year drop in revenue in its other segment, with an operating margin reduction to 7.5% despite some improvement in gross margin metrics. The overall financial performance was further impacted by a substantial 31% decline in vendor management services (VMS) revenue, highlighting challenges in maintaining growth and profitability across key business areas.
This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.
AMN Analyst Forecast & Price Prediction
Start investing in AMN
Order type
Buy in
Order amount
Est. shares
0 shares